The specific potential mechanism between non-apoptotic programmed cell death-related genes and TP53 mutation, liver cancer cell stemness, tumor microenvironment, or TACE therapy sensitivity in HCC remains unclear, which is worthy of further study. Here, TP53 is linked to liver cancer.